Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
DPP Syphilis Screen & Confirm
print preview
bookmark
share with colleague
General Information
Company
Chembio Diagnostics Inc.
Description
Point-of-care assay using Dual Path Platform (DPP) technology to detect non-treponemal and treponemal antibodies to syphilis in blood
Molecular Target
Mechanism of Action
Diagnostic; Antibody
Latest Stage of Development
Marketed
Indication
Infectious, Diagnostic
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy